Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $812000.0.

  • Conmed's Deferred Taxes fell 8765.21% to $812000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.5 million, marking a year-over-year decrease of 7112.77%. This contributed to the annual value of $3.5 million for FY2025, which is 7112.77% down from last year.
  • Latest data reveals that Conmed reported Deferred Taxes of $812000.0 as of Q4 2025, which was down 8765.21% from $3.7 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Deferred Taxes registered a high of $70.2 million during Q2 2022, and its lowest value of -$44.5 million during Q4 2022.
  • Moreover, its 5-year median value for Deferred Taxes was $859500.0 (2021), whereas its average is $669400.0.
  • Data for Conmed's Deferred Taxes shows a peak YoY increase of 764255.79% (in 2022) and a maximum YoY decrease of 690000.0% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows Conmed's Deferred Taxes stood at $4.3 million in 2021, then tumbled by 1130.68% to -$44.5 million in 2022, then surged by 103.58% to $1.6 million in 2023, then skyrocketed by 313.32% to $6.6 million in 2024, then tumbled by 87.65% to $812000.0 in 2025.
  • Its Deferred Taxes stands at $812000.0 for Q4 2025, versus $3.7 million for Q3 2025 and $1.7 million for Q2 2025.